Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1
Tài liệu tham khảo
Weiser, 2018, Streptococcus pneumoniae: transmission, colonization and invasion, Nat. Rev. Microbiol., 16, 355, 10.1038/s41579-018-0001-8
Andrade, 2011, Pneumococcal disease manifestation in children before and after vaccination: what’s new?, Vaccine, 29, C2, 10.1016/j.vaccine.2011.06.096
World Health Organization WHO, 2007, Pneumococcal conjugate vaccine for childhood immunization - WHO position paper, Bull. Epidemiol. Inf. Receiv., 82, 93
Donlan, 2002, Biofilms: Microbial life on surfaces, Emerg. Infect. Dis., 8, 881, 10.3201/eid0809.020063
Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318
Tacconelli, 2017, 1
López, 2004, Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage, FEMS Microbiol. Rev., 28, 553, 10.1016/j.femsre.2004.05.002
Kot, 2017, Complete genome sequence of Streptococcus pneumoniae virulent Phage MS1, Genome Announc., 5, 4, 10.1128/genomeA.00333-17
Loeffler, 2001, Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase, Science, 294, 2170, 10.1126/science.1066869
Loeffler, 2003, Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains, Antimicrob. Agents Chemother., 47, 375, 10.1128/AAC.47.1.375-377.2003
Djurkovic, 2005, Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance, Antimicrob. Agents Chemother., 49, 1225, 10.1128/AAC.49.3.1225-1228.2005
Loeffler, 2003, Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia, Infect. Immun., 71, 6199, 10.1128/IAI.71.11.6199-6204.2003
Entenza, 2005, Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats, Antimicrob. Agents Chemother., 49, 4789, 10.1128/AAC.49.11.4789-4792.2005
McCullers, 2007, Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae, PLoS Pathog., 3, e28, 10.1371/journal.ppat.0030028
Maestro, 2016, Choline binding proteins from Streptococcus pneumoniae: a dual role as enzybiotics and targets for the design of new antimicrobials, Antibiotics, 5, 21, 10.3390/antibiotics5020021
Finn, 2016, The Pfam protein families database: towards a more sustainable future, Nucleic Acids Res., 44, D279, 10.1093/nar/gkv1344
Sigrist, 2013, New and continuing developments at PROSITE, Nucleic Acids Res.
Gasteiger, 2005, Protein identification and analysis tools on the ExPASy server, 571
Larkin, 2007, Clustal W and Clustal X version 2.0, Bioinformatics, 10.1093/bioinformatics/btm404
Sambrook, 2001
Harhala, 2018, Safety studies of pneumococcal endolysins Cpl-1 and Pal, Viruses, 10, 638, 10.3390/v10110638
Oliveira, 2016, Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-Gram-negative bacterial activity, Front. Microbiol., 7, 1, 10.3389/fmicb.2016.00208
Compton, 1986, Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication, Anal. Biochem., 155, 155, 10.1016/0003-2697(86)90241-1
Van Stokkum, 1990, Estimation of protein secondary structure and error analysis from circular dichroism spectra, Anal. Biochem., 10.1016/0003-2697(90)90396-Q
Whitmore, 2004, DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data, Nucleic Acids Res., 10.1093/nar/gkh371
McGuffin, 2000, The PSIPRED protein structure prediction server, Bioinformatics, 10.1093/bioinformatics/16.4.404
Centers for Disease Control and Prevention, Conventional PCR Serotype Deduction Protocols, (n.d.). https://www.cdc.gov/streplab/pneumococcus/resources.html.
Pai, 2006, Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniaeisolates, J. Clin. Microbiol., 44, 124, 10.1128/JCM.44.1.124-131.2006
Merritt, 2005, Growing and analyzing static biofilms
Sheehan, 1997, The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin, Mol. Microbiol., 25, 717, 10.1046/j.1365-2958.1997.5101880.x
Domenech, 2011, In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases, Antimicrob. Agents Chemother., 55, 4144, 10.1128/AAC.00492-11
Kurola, 2010, Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infection, J. Med. Microbiol., 59, 1140, 10.1099/jmm.0.016956-0
Xu, 2011, Nontypeable Streptococcus pneumoniae as an otopathogen, Diagn. Microbiol. Infect. Dis., 69, 200, 10.1016/j.diagmicrobio.2010.09.019
Keller, 2016, Nonencapsulated Streptococcus pneumoniae: emergence and pathogenesis, MBio, 7, 1, 10.1128/mBio.01792-15
Murrah, 2015, Nonencapsulated Streptococcus pneumoniae causes otitis media during single-species infection and during polymicrobial infection with nontypeable Haemophilus influenzae, Pathog. Dis., 73, 1, 10.1093/femspd/ftu011
Portuguese Directorate-General of Health, 2017, 1
Blázquez, 2016, PL3 amidase, a tailor-made lysin constructed by domain shuffling with potent killing activity against pneumococci and related species, Front. Microbiol., 7, 1, 10.3389/fmicb.2016.01156
Bustamante, 2010, Cpl-7, a lysozyme encoded by a pneumococcal bacteriophage with a novel cell wall-binding motif, J. Biol. Chem., 285, 33184, 10.1074/jbc.M110.154559
Díez-Martínez, 2013, Improving the lethal effect of Cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module, Antimicrob. Agents Chemother., 57, 5355, 10.1128/AAC.01372-13
Varea, 2004, Structural and thermodynamic characterization of Pal, a phage natural chimeric lysin active against Pneumococci, J. Biol. Chem., 279, 43697, 10.1074/jbc.M407067200
Diez-Martinez, 2015, A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae, J. Antimicrob. Chemother., 70, 1763, 10.1093/jac/dkv038
Sanz, 1990, Structural studies of the lysozyme coded by the pneumococcal phage Cp-1. Conformational changes induced by choline, Eur. J. Biochem., 187, 409, 10.1111/j.1432-1033.1990.tb15319.x
Levander, 2017, Variation in normal ear temperature, Am. J. Med. Sci., 354, 370, 10.1016/j.amjms.2017.05.013
Wezyk, 2000, pH of fluid collected from middle ear in the course of otitis media in children, Otolaryngol. Pol., 54, 131
Maestro, 2007, Inhibition of pneumococcal choline-binding proteins and cell growth by esters of bicyclic amines, FEBS J., 274, 364, 10.1111/j.1742-4658.2006.05584.x
Hall-Stoodley, 2006, Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media, JAMA, 296, 202, 10.1001/jama.296.2.202
Hoa, 2009, Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH, Int. J. Pediatr. Otorhinolaryngol., 73, 1242, 10.1016/j.ijporl.2009.05.016
Vázquez, 2019, Synergy between two chimeric lysins to kill Streptococcus pneumoniae, Front. Microbiol., 10, 1, 10.3389/fmicb.2019.01251
Resch, 2011, A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance, Int. J. Antimicrob. Agents, 38, 516, 10.1016/j.ijantimicag.2011.08.009
